Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

FDA approves Descovy, an updated version of Truvada—but not for PrEP

FDA approves Descovy, an updated version of Truvada—but not for PrEP

, by Liz Highleyman

An updated tenofovir alafenamide combo pill is now available from Gilead Sciences, but it should not be substituted for Truvada as PrEP. Read More

Should there be more frequent STI screening for people on PrEP?

Should there be more frequent STI screening for people on PrEP?

, by Liz Highleyman

Current CDC guidelines recommend STI testing every 6 months, but this may not be frequent enough. Read More

New research at CROI 2016: How PrEP changes kidney function

New research at CROI 2016: How PrEP changes kidney function

, by Liz Highleyman

Changes in kidney function with PrEP is not common but may warrant additional screening for people at risk. Read More

New HIV treatments discussed at CROI 2016

New HIV treatments discussed at CROI 2016

, by Liz Highleyman

Long-acting HIV therapy injections and a newer formulation of tenofovir did well in clinical trials. Read More

The U.S. HIV epidemic at CROI 2016: Black gay men have a 1 in 2 lifetime risk

The U.S. HIV epidemic at CROI 2016: Black gay men have a 1 in 2 lifetime risk

, by Liz Highleyman

Studies on epidemiological data highlight disparities in HIV according to race and risk factor. Read More